A local institute is a leading center for Alzheimer’s treatment and research, and is offering a free medication program to the public for the treatment of Alzheimer’s and memory problems.
People who are experiencing memory issues and have not yet been diagnosed may come in to the Princeton Medical Institute for a free evaluation to see if they have Alzheimer’s or a pre-Alzheimer’s condition. There’s no obligation to enter the study, but those who do will be provided with free medication, free physical exams, and travel reimbursement.
“We are working with medications we hope will prevent the progression of the illness,” said Jeffrey T. Apter, M.D., president and principle investigator at Princeton Medical Institute, and a senior attending physician at University Medical Center at Princeton. “That’s quite different from current medications which are on the market and are helping with the symptoms.”
Dr. Apter’s current study includes a new generation of medications aimed at preventing the accumulation of the “bad protein” in the brain. Study participants may be just starting to see memory issues and currently are undiagnosed, or may be those with a diagnosis who already are on other medications.
“We provide year-round free memory screenings for those who feel, or whose loved ones have noticed, that their memory is much worse than what it should be for their age,” Dr. Apter explained. “We ask potential participants to bring a friend or loved one to the screening so that person can help provide history and corroborate the information provided. There’s no obligation to enter the study; sometimes people are just looking for answers.”
Alzheimer’s is a very common disorder associated with aging. Dr. Apter, who has been involved in Alzheimer’s studies for more than 15 years, and worked on studies for the currently available medications, says by age 65, 3 percent of the population has memory issues. By 85, almost 50 percent have been diagnosed. By 2050, it’s estimated 16 million people will have the disease; that’s why he’s committed to trying to find a way to slow the progression.
“It takes a long time before medications qualify for FDA approval,” he added. “There’s at least five years in clinical trials before the drugs can come into the marketplace. Our studies take place under the FDA’s supervision and ethics review boards’ requirements.”
Dr. Apter’s reputation precedes him – people come from all over New Jersey and Pennsylvania for memory-loss evaluations and to participate in his studies. Anyone interested in being evaluated, or in bringing a loved on in for evaluation, may call Princeton Medical Institute’s special number for this trial: 609-921-6050.
Princeton Medical Institute. Woodlands Professional Building, 256 Bunn Drive, Suite 6, Princeton. 609-921-6050. firstname.lastname@example.org, www.gminstitutes.com.